Castle Biosciences Inc (CSTL): Depreciation & Amortization
$40.77M
Year ended 2025-12-31
$15.59M
Trailing 12 months to 2026-06-30
+57.0%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $40.77M | +154.9% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $16.00M | +29.7% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $12.33M | +16.9% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $10.54M | +209.5% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $3.41M | +621.8% | 2023-02-28, From 2021-01-01 |
| 2020-12-31 | $472.0K | n/a | 2022-02-28, From 2020-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $40.77M | +154.9% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $24.12M | -3.2% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $15.02M | +5.8% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $6.90M | -1.4% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $21.41M | -8.7% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $22.61M | -53.8% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $39.74M | -6.3% |
| Biodesix Inc (BDSX) | 2025-12-31 | $5.67M | -1.8% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $10.05M | -8.2% |
Compare CSTL, FLGT, CDNA, BLLN side by side · Screen every company in Services-Medical Laboratories ↗